2020
Genetic characterization of an aggressive optic nerve pilocytic glioma
Hong CS, Fliney G, Fisayo A, An Y, Gopal PP, Omuro A, Pointdujour-Lim R, Erson-Omay EZ, Omay SB. Genetic characterization of an aggressive optic nerve pilocytic glioma. Brain Tumor Pathology 2020, 38: 59-63. PMID: 33098465, PMCID: PMC7585354, DOI: 10.1007/s10014-020-00383-x.Peer-Reviewed Original ResearchConceptsOptic nerve gliomaLeft optic nerve sheathLeft-sided visual lossSporadic adult casesOptic nerve sheathNeurofibromatosis type 1 syndromeType 1 syndromeWhole-exome sequencingEmpiric managementVisual lossFocal radiotherapyOptic nervePediatric populationNerve sheathOpen biopsyAdult casesBiopsy specimenBenign histopathologyClinical prognosticationPilocytic astrocytomaComplex tumorsActionable targetsVisual pathwayAdult populationTumor progression
2014
MicroRNA-124 expression counteracts pro-survival stress responses in glioblastoma
Mucaj V, Lee S, Skuli N, Giannoukos D, Qiu B, Eisinger-Mathason T, Nakazawa M, Shay J, Gopal P, Venneti S, Lal P, Minn A, Simon M, Mathew L. MicroRNA-124 expression counteracts pro-survival stress responses in glioblastoma. Oncogene 2014, 34: 2204-2214. PMID: 24954504, PMCID: PMC4275412, DOI: 10.1038/onc.2014.168.Peer-Reviewed Original ResearchConceptsMiR-124 expressionMiR-124 levelsGlioblastoma patient samplesTumor cell survivalPatient samplesAggressive adult brain tumorCell survivalCell deathSurvival of miceAdult brain tumorsHypoxic gene signaturePoor patient outcomesIntracranial xenograft tumorsHypoxic cell deathIncreases cell deathPatient outcomesTumor ischemiaXenograft tumorsBrain tumorsGlioblastoma patientsIschemic regionTherapeutic resistanceTumor progressionCancer typesGene signature